发明名称 |
MODIFIED ANTIBODY WITH ENHANCED BIOLOGICAL ACTIVITY |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide methods for enhancing effector activities of antibodies. <P>SOLUTION: Modified antibodies in which Fc domains are linked in tandem to the C terminus of the heavy chain, and modified antibodies in which Fc domains are linked in tandem via spacers are produced; and the affinity for Fc receptors, CDC activity, and ADCC activity are measured. It has been reported that the CDC activity is not enhanced even if multiple Fcs are linked. However the modified antibodies exhibit the enhanced ADCC activity. The methods enable provision of antibody pharmaceuticals having a marked therapeutic effect. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2012136519(A) |
申请公布日期 |
2012.07.19 |
申请号 |
JP20120004674 |
申请日期 |
2012.01.13 |
申请人 |
TOKYO UNIV OF SCIENCE;CHEMO-SERO-THERAPEUTIC RESEARCH INST;TEIJIN PHARMA LTD |
发明人 |
MASUYASU YASUHIKO;NAGASHIMA HIROAKI |
分类号 |
C07K16/18;A61K39/395;C07K16/28;C12N15/09;C12P21/02 |
主分类号 |
C07K16/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|